BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10939962)

  • 1. Toxicogenomics. Toxicologists brace for genomics revolution.
    Lovett RA
    Science; 2000 Jul; 289(5479):536-7. PubMed ID: 10939962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomics: an in vitro toxicology point of view.
    Corvi R
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():129-31. PubMed ID: 12513664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression analysis reveals chemical-specific profiles.
    Hamadeh HK; Bushel PR; Jayadev S; Martin K; DiSorbo O; Sieber S; Bennett L; Tennant R; Stoll R; Barrett JC; Blanchard K; Paules RS; Afshari CA
    Toxicol Sci; 2002 Jun; 67(2):219-31. PubMed ID: 12011481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiles in rat liver slices exposed to hepatocarcinogenic enzyme inducers, peroxisome proliferators, and 17alpha-ethinylestradiol.
    Werle-Schneider G; Wölfelschneider A; von Brevern MC; Scheel J; Storck T; Müller D; Glöckner R; Bartsch H; Bartelmann M
    Int J Toxicol; 2006; 25(5):379-95. PubMed ID: 16940010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative methods for developmental toxicity testing.
    Piersma AH
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):427-31. PubMed ID: 16635099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inverse gene expression patterns for macrophage activating hepatotoxicants and peroxisome proliferators in rat liver.
    McMillian M; Nie AY; Parker JB; Leone A; Kemmerer M; Bryant S; Herlich J; Yieh L; Bittner A; Liu X; Wan J; Johnson MD
    Biochem Pharmacol; 2004 Jun; 67(11):2141-65. PubMed ID: 15135310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-species comparative toxicogenomics as an aid to safety assessment.
    Mattes WB
    Expert Opin Drug Metab Toxicol; 2006 Dec; 2(6):859-74. PubMed ID: 17125406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Literature-based compound profiling: application to toxicogenomics.
    Frijters R; Verhoeven S; Alkema W; van Schaik R; Polman J
    Pharmacogenomics; 2007 Nov; 8(11):1521-34. PubMed ID: 18034617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription profiling distinguishes dose-dependent effects in the livers of rats treated with clofibrate.
    Kramer JA; Blomme EA; Bunch RT; Davila JC; Jackson CJ; Jones PF; Kolaja KL; Curtiss SW
    Toxicol Pathol; 2003; 31(4):417-31. PubMed ID: 12851107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomics and proteomics analysis of cultured primary rat hepatocytes.
    Beigel J; Fella K; Kramer PJ; Kroeger M; Hewitt P
    Toxicol In Vitro; 2008 Feb; 22(1):171-81. PubMed ID: 17768030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The promise of toxicogenomics.
    Waring JF; Halbert DN
    Curr Opin Mol Ther; 2002 Jun; 4(3):229-35. PubMed ID: 12139308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicogenomics; transcript profiling and potential application to chemical allergy.
    Pennie WD; Kimber I
    Toxicol In Vitro; 2002 Jun; 16(3):319-26. PubMed ID: 12020605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicogenomics in the pharmaceutical industry: hollow promises or real benefit?
    Lühe A; Suter L; Ruepp S; Singer T; Weiser T; Albertini S
    Mutat Res; 2005 Aug; 575(1-2):102-15. PubMed ID: 15924886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Phalen RF
    Hum Exp Toxicol; 2010 Jan; 29(1):11-4. PubMed ID: 20061462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How omics technologies can contribute to the '3R' principles by introducing new strategies in animal testing.
    Kroeger M
    Trends Biotechnol; 2006 Aug; 24(8):343-6. PubMed ID: 16782220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA microarrays: an overview of technologies and applications to toxicology.
    Zarbl H
    Curr Protoc Toxicol; 2001; Chapter 1():Unit1.4. PubMed ID: 23045022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of genomics to the definition of the molecular basis for toxicity.
    Pennie WD; Woodyatt NJ; Aldridge TC; Orphanides G
    Toxicol Lett; 2001 Mar; 120(1-3):353-8. PubMed ID: 11323194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of toxicogenomics to toxicology: basic concepts in the analysis of microarray data.
    Irwin RD; Boorman GA; Cunningham ML; Heinloth AN; Malarkey DE; Paules RS
    Toxicol Pathol; 2004; 32 Suppl 1():72-83. PubMed ID: 15209406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Schwartz SL
    Hum Exp Toxicol; 2010 Jan; 29(1):15-9. PubMed ID: 20061463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humane science finds sharper and kinder tools.
    Stokstad E
    Science; 1999 Nov; 286(5442):1068-71. PubMed ID: 10610517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.